Literature DB >> 11092772

Intranasal midazolam as an alternative to general anaesthesia in the management of children with oral and maxillofacial trauma.

C J Lloyd1, T Alredy, J C Lowry.   

Abstract

The study assessed the dosage, clinical sedative effect, and safety of intranasal midazolam in 32 children. Data were complete for 29 patients (21 with lacerations and 8 cases of dental trauma). Sedation was adequate to ensure successful completion of treatment under local with or without topical anaesthetic in 22 of the 29 cases (76%). They became sedated at a mean (SD) of 14 (5) minutes, with completion of treatment at 20 (13) minutes. Sedation was achieved with a mean (SD) of 5 (2)mg of midazolam. There were no signs of respiratory depression or of oxygen desaturation below 94% on pulse oximetry. No supplemental oxygen was required and there were no other complications. We conclude that intranasal midazolam is a safe and effective alternative to general anaesthesia in the definitive treatment of children with oral and maxillofacial injuries. Copyright 2000 The British Association of Oral and Maxillofacial Surgeons.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11092772     DOI: 10.1054/bjom.2000.0534

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  6 in total

1.  Low-dose intranasal versus oral midazolam for routine body MRI of claustrophobic patients.

Authors:  Frank T C Tschirch; Kerstin Göpfert; Johannes M Fröhlich; Genevieve Brunner; Dominik Weishaupt
Journal:  Eur Radiol       Date:  2006-11-09       Impact factor: 5.315

2.  Comparison of the Sedative Effect of Inhaled Nitrous Oxide and Intranasal Midazolam in Behavior Management and Pain Perception of Pediatric Patients: A Split-mouth Randomized Controlled Clinical Trial.

Authors:  Navaneetha Krishnan Srinivasan; Pradeep Karunagaran; Veerale Panchal; Emg Subramanian
Journal:  Int J Clin Pediatr Dent       Date:  2021

Review 3.  Evaluation of Intranasal Midazolam for Pediatric Sedation during the Suturing of Traumatic Lacerations: A Systematic Review.

Authors:  Francisco Javier Gómez-Manzano; José Alberto Laredo-Aguilera; Ana Isabel Cobo-Cuenca; Joseba Rabanales-Sotos; Sergio Rodríguez-Cañamero; Noelia Martín-Espinosa; Juan Manuel Carmona-Torres
Journal:  Children (Basel)       Date:  2022-04-29

4.  Comparative Analysis of Intravenous Midazolam with Nasal Spray for Conscious Sedation in Minor Oral and Maxillofacial Surgeries.

Authors:  Ramesh Kunusoth; Gururam Tej; Kranti Kiran Reddy Ealla; Pavan Kumar Kathuroju; Anusha Ayyagari; Aditya Mohan Alwala
Journal:  J Pharm Bioallied Sci       Date:  2019-02

5.  Comparative Evaluation of the Intranasal Spray Formulation of Midazolam and Dexmedetomidine in Patients Undergoing Surgical Removal of Impacted Mandibular Third Molars: A Split Mouth Prospective Study.

Authors:  Shashank Hiwarkar; Rajesh Kshirsagar; Vikram Singh; Amod Patankar; Sanjay Chandan; Mukund Rathod; Ajay Mohite
Journal:  J Maxillofac Oral Surg       Date:  2016-12-18

6.  Utility of intranasal Ketamine and Midazolam to perform gastric aspirates in children: a double-blind, placebo controlled, randomized study.

Authors:  Danilo Buonsenso; Giovanni Barone; Piero Valentini; Filomena Pierri; Riccardo Riccardi; Antonio Chiaretti
Journal:  BMC Pediatr       Date:  2014-03-05       Impact factor: 2.125

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.